Used primarily in pharmaceutical research as an intermediate in the synthesis of biologically active compounds, particularly in the development of immunomodulatory and anticancer agents. Its structural features make it suitable for modifying peptide-like molecules to enhance stability and receptor binding. It has been explored in the design of targeted protein degradation therapeutics, such as PROTACs, due to its ability to interact with E3 ubiquitin ligases. Also investigated for use in treatments involving inflammation and neurodegenerative diseases owing to its cell signaling modulation properties.